Servier Laboratories

Founded in 1954, Servier is a leading pharmaceutical group with a presence in 140 countries.

The Servier Foundation was established in 2005 by company founder Dr Jacques Servier, with the aim that all profit from worldwide operations goes back into the research and development of medicines.

Servier Australia's commercial interests are presently in cardiovascular disease (Coveram - perindopril and amlodipine, Coversyl - perindopril arginine and Coralan - ivabradine), and more recently, major depression with the registration of Valdoxan (agomelatine).

Show On Map